ZYBT
Income statement / Annual
Last year (2025), Zhengye Biotechnology Holding Ltd.'s total revenue was $116.36 M,
a decrease of 37.56% from the previous year.
In 2025, Zhengye Biotechnology Holding Ltd.'s net income was -$69.78 M.
See Zhengye Biotechnology Holding Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$116.36 M |
$186.36 M |
$211.65 M |
$260.27 M |
$214.07 M |
| Cost of Revenue |
$92.49 M
|
$95.06 M
|
$81.80 M
|
$106.75 M
|
$88.67 M
|
| Gross Profit |
$23.87 M
|
$91.30 M
|
$129.86 M
|
$153.52 M
|
$125.39 M
|
| Gross Profit Ratio |
0.21
|
0.49
|
0.61
|
0.59
|
0.59
|
| Research and Development Expenses |
$18.01 M
|
$12.79 M
|
$11.90 M
|
$13.42 M
|
$11.37 M
|
| General & Administrative Expenses |
$31.01 M
|
$22.58 M
|
$25.89 M
|
$28.99 M
|
$22.29 M
|
| Selling & Marketing Expenses |
$43.92 M
|
$41.27 M
|
$40.74 M
|
$34.57 M
|
$35.90 M
|
| Selling, General & Administrative Expenses |
$74.92 M
|
$63.84 M
|
$66.63 M
|
$63.56 M
|
$58.19 M
|
| Other Expenses |
-$814.00 K
|
-$1.78 M
|
$6.33 M
|
$10.70 M
|
$3.45 M
|
| Operating Expenses |
$92.12 M
|
$74.86 M
|
$84.87 M
|
$87.69 M
|
$73.01 M
|
| Cost And Expenses |
$184.62 M
|
$169.92 M
|
$166.67 M
|
$194.44 M
|
$161.68 M
|
| Interest Income |
$96.00 K
|
$231.00 K
|
$312.00 K
|
$114.00 K
|
$112.00 K
|
| Interest Expense |
$3.40 M
|
$4.04 M
|
$4.42 M
|
$2.84 M
|
$1.05 M
|
| Depreciation & Amortization |
$25.96 M
|
$24.16 M
|
$23.91 M
|
$18.80 M
|
$16.01 M
|
| EBITDA |
-$42.52 M |
$42.60 M |
$72.10 M |
$85.55 M |
$70.12 M |
| EBITDA Ratio |
-0.37
|
0.23
|
0.34
|
0.33
|
0.33
|
| Operating Income Ratio |
-0.59
|
0.09
|
0.21
|
0.25
|
0.24
|
| Total Other Income/Expenses Net |
-$3.62 M
|
-$2.05 M
|
-$1.22 M
|
-$1.92 M
|
$683.00 K
|
| Income Before Tax |
-$71.87 M
|
$14.39 M
|
$43.76 M
|
$63.91 M
|
$53.07 M
|
| Income Before Tax Ratio |
-0.62
|
0.08
|
0.21
|
0.25
|
0.25
|
| Income Tax Expense |
$11.10 M
|
$924.00 K
|
$6.25 M
|
$8.17 M
|
$6.60 M
|
| Net Income |
-$69.78 M
|
$11.31 M
|
$31.46 M
|
$46.74 M
|
$38.96 M
|
| Net Income Ratio |
-0.6
|
0.06
|
0.15
|
0.18
|
0.18
|
| EPS |
0 |
0.24 |
0.69 |
1.02 |
0.85 |
| EPS Diluted |
0 |
0.24 |
0.67 |
0.99 |
0.83 |
| Weighted Average Shares Out |
$0.00
|
$47.17 M
|
$45.67 M
|
$45.67 M
|
$45.67 M
|
| Weighted Average Shares Out Diluted |
$0.00
|
$47.17 M
|
$47.17 M
|
$47.17 M
|
$47.17 M
|
| Link |
|
|
|
|
|
